BioInfra Life Science Inc. (XKON: 266470)
South Korea
· Delayed Price · Currency is KRW
284.00
-2.00 (-0.70%)
Sep 10, 2024, 9:00 AM KST
BioInfra Life Science Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| Sep '24 Sep 9, 2024 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
| Debt / Equity Ratio | -8.67 | -91.12 | 0.15 | 0.14 | 0.06 |
| Debt / FCF Ratio | -3.54 | -3.47 | -0.11 | -0.18 | -0.15 |
| Asset Turnover | 0.23 | 0.21 | 0.26 | 0.16 | - |
| Quick Ratio | 1.66 | 1.87 | 3.72 | 3.30 | 20.98 |
| Current Ratio | 1.67 | 1.87 | 3.87 | 4.10 | 23.67 |
| Return on Equity (ROE) | -746.61% | -230.95% | -100.74% | -58.82% | - |
| Return on Assets (ROA) | -28.10% | -23.72% | -37.93% | -23.33% | - |
| Return on Capital (ROIC) | -37.22% | -30.83% | -52.27% | -26.34% | - |
| Buyback Yield / Dilution | 2.59% | 1.87% | -6.28% | -1.42% | - |
| Total Shareholder Return | 2.59% | 1.87% | -6.28% | -1.42% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.